<code id='7A124F0ACC'></code><style id='7A124F0ACC'></style>
    • <acronym id='7A124F0ACC'></acronym>
      <center id='7A124F0ACC'><center id='7A124F0ACC'><tfoot id='7A124F0ACC'></tfoot></center><abbr id='7A124F0ACC'><dir id='7A124F0ACC'><tfoot id='7A124F0ACC'></tfoot><noframes id='7A124F0ACC'>

    • <optgroup id='7A124F0ACC'><strike id='7A124F0ACC'><sup id='7A124F0ACC'></sup></strike><code id='7A124F0ACC'></code></optgroup>
        1. <b id='7A124F0ACC'><label id='7A124F0ACC'><select id='7A124F0ACC'><dt id='7A124F0ACC'><span id='7A124F0ACC'></span></dt></select></label></b><u id='7A124F0ACC'></u>
          <i id='7A124F0ACC'><strike id='7A124F0ACC'><tt id='7A124F0ACC'><pre id='7A124F0ACC'></pre></tt></strike></i>

          entertainment

          entertainment

          author:focus    Page View:8163
          Sammy Kimball for STAT

          Why do CEOs talk like that? Do biotech stock tips make good gifts? And what do Anthony Fauci and Stéphane Bancel have in common?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we discuss why Wall Street was less than convinced by Biogen’s attempt to assuage concerns about its credibility. Then we explain an insider trading scandal that bridges biotech and elite-level soccer, the latest concerns over Wegovy, and the rest of the week’s news in the life sciences. We also break some bittersweet news, with the help of some headline names from around biotech.

          advertisement

          For more on what we cover, here’s the Biogen news; here are the charges against Joe Lewis; here’s the latest on Wegovy; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          focus

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          Baby aspirin cuts fat buildup in liver disease patients, in small study
          Baby aspirin cuts fat buildup in liver disease patients, in small study

          PatrickSison/APLow-doseaspirinledtoareductioninliverfatamongpatientswithmetabolic-associatedliverdis

          read more
          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more

          Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

          NovoNordiskviaAPPHILADELPHIA—NovoNordisk’sobesitydrugWegovynotablycuttheriskofheartattacksinalandmar